Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Trial offers hope for koala chlamydia vaccine
koala
“Chlamydia is one of the major threats to our koala populations".

Scientists report world's first successful trial involving wild koalas

Australian scientists have carried out the world's first successful trial of a vaccine against chlamydia in koala bears.

Microbiologists from the University of Sunshine Coast (USC) in Queensland have spent five years leading the research. In previous studies, the team trialled the vaccine on captive koalas, but for the past year they have been testing its effects in wild animals.

Sixty koalas were captured from their natural habitat in the Moreton Bay region north of Brisbane. Half were vaccinated, while the remaining thirty were left unvaccinated as a control group. Each koala was fitted with a radio tag for monitoring purposes.

Professor Timms, who led the research, said the results were "very promising". The vaccinated koalas showed good immune responses and lower levels of chlamydia infection than the unvaccinated group.

“This large trial has confirmed that the vaccine is safe to give to not only captive koalas, but also koalas in the wild,” he said.

However, the trial will continue for at least another year. The team hope to show the vaccine's positive impacts on disease and female reproductivity, as well as infection.

Professor Timms also hopes to assess the vaccine's impact on other koala populations facing the threat of chlamydial disease, but this will require further funding.

“We feel compelled to start using this vaccine more broadly, especially when we know that it is safe and has some definite positive benefit to the animals,” he said.

“But a project of this size and cost requires a large team of people, including veterinarians and field teams, in addition to the laboratory aspects.”

The Queensland Government provided funding of $358,000 to the trial. State environment minister Andrew Powell said: “Chlamydia is one of the major threats to our koala populations and that’s why we’ve invested significant funds into combating this disease.

“Among other things, chlamydia in koalas can lead to blindness and infertility, so it’s clear why we need to support research that can stem these conditions.”
A special fund has been set up for those wishing to offer donations to the project:
http://www.usc.edu.au/community/giving-to-usc/giving-opportunities/koala-research-project

To watch a video of the researchers discussing their work, visit: http://www.youtube.com/watch?v=yrfbHfO76e0&feature=youtu.be

Become a member or log in to add this story to your CPD history

Birmingham Dogs Home makes urgent appeal

News Story 1
 Birmingham Dogs Home has issued an urgent winter appeal as it faces more challenges over the Christmas period.

The rescue centre has seen a dramatic increase in dogs coming into its care, and is currently caring for over 200 dogs. With rising costs and dropping temperatures, the charity is calling for urgent support.

It costs the charity £6,000 per day to continue its work.

Fi Harrison, head of fundraising and communications, said: "It's heart-breaking for our team to see the conditions some dogs arrive in. We really are their last chance and hope of survival."

More information about the appeal can be found here

Click here for more...
News Shorts
Avian flu confirmed at premises in Cornwall

A case of highly pathogenic avian influenza H5N1 has been detected in commercial poultry at a premises near Rosudgeon, Cornwall.

All poultry on the infected site will be humanely culled, and a 3km protection zone and 10km surveillance zone have been put in place. Poultry and other captive birds in the 3km protection zone must be housed.

The case is the second avian flu case confirmed in commercial poultry this month. The H5N5 strain was detected in a premises near Hornsea, East Riding of Yorkshire, in early November. Before then, the disease had not been confirmed in captive birds in England since February.

The UK chief veterinary officer has urged bird keepers to remain alert and practise robust biosecurity.

A map of the disease control zones can be found here.